Invus Financial Advisors, LLC Unity Biotechnology, Inc. Transaction History

Invus Financial Advisors, LLC

  • $89.2 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.72 - $1.86 $788,398 - $2.04 Million
-1,094,998 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$2.94 - $12.43 $3.22 Million - $13.6 Million
-1,095,000 Reduced 50.0%
1,094,998 $3.79 Million
Q4 2019

Feb 13, 2020
BUY
$5.99 - $8.38 $13.1 Million - $18.4 Million
2,189,998 New
2,189,998 $15.8 Million

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0
View Full List

About Unity Biotechnology, Inc.

UBX Quotes by TradingView
  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $14M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track Invus Financial Advisors, LLC Portfolio

Follow Invus Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invus Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invus Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email